Safety and Performance of Journey II XR Total Knee System
NCT ID: NCT03798847
Last Updated: 2023-07-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
683 participants
OBSERVATIONAL
2018-11-01
2020-09-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
JOURNEY II XR Safety and Effectiveness PMCF
NCT03136887
Safety and Performance of JOURNEY™ II Cruciate Retaining (CR) Total Knee System (TKS)
NCT03885531
JOURNEY™ II CR Total Knee System
NCT02440672
Journey 2 Multi Center Kinematic Study
NCT05107414
Safety and Performance of Journey II BCS Total Knee System Patient Reported Outcome Measures
NCT03903731
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
RETROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Journey II XR TKA
Journey II XR Total Knee System
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The TKA occurred at least 12 weeks prior to enrollment.
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Smith & Nephew, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Orthopedic Institute of the West
Phoenix, Arizona, United States
Rush Copley Orthopaedics
Aurora, Illinois, United States
Jerry Orthopaedic Institute
Port Huron, Michigan, United States
Reno Orthopedic Clinic
Reno, Nevada, United States
Orthopaedic Center of New Jersey
Somerset, New Jersey, United States
Hospital for Joint Diseases Orthopaedics Institute
New York, New York, United States
Regenerative Orthopedic Center (ROC)
Oregon City, Oregon, United States
Oregon Health & Science University
Portland, Oregon, United States
San Antonio Orthopaedic Specialists
San Antonio, Texas, United States
Anderson Orthopaedic Clinic
Alexandria, Virginia, United States
Scott Orthopedic Center
Huntington, West Virginia, United States
Aurora Medical Center
Kenosha, Wisconsin, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
JIIXR.PMCF.2018.13
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.